Company registration number 1824905 (England and Wales)
INTERNATIONAL PHEROMONE SYSTEMS LIMITED
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
INTERNATIONAL PHEROMONE SYSTEMS LIMITED
CONTENTS
Page
Director's report
1
Accountants' report
2
Balance sheet
3 - 4
Notes to the financial statements
5 - 8
INTERNATIONAL PHEROMONE SYSTEMS LIMITED
DIRECTOR'S REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 1 -

The director presents his annual report and financial statements for the year ended 31 December 2025.

Principal activities

The principal activity of the company continued to be that of the manufacture of products to monitor and manage pests in agricultural and domestic environments.

Director

The director who held office during the year and up to the date of signature of the financial statements was as follows:

Mr G Hartley
Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
Mr G Hartley
Director
8 July 2026
INTERNATIONAL PHEROMONE SYSTEMS LIMITED
ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF INTERNATIONAL PHEROMONE SYSTEMS LIMITED FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of International Pheromone Systems Limited for the year ended 31 December 2025 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

This report is made solely to the b oard of d irectors of International Pheromone Systems Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of International Pheromone Systems Limited and state those matters that we have agreed to state to the b oard of d irectors of International Pheromone Systems Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than International Pheromone Systems Limited and its b oard of d irectors as a body, for our work or for this report.

It is your duty to ensure that International Pheromone Systems Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of International Pheromone Systems Limited. You consider that International Pheromone Systems Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of International Pheromone Systems Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory f inancial statements.

Xeinadin North Limited
Xeinadin Warrington
Building C Concentric
Warrington Road
Warrington
Cheshire
WA3 6WX
United Kingdom
8 July 2026
INTERNATIONAL PHEROMONE SYSTEMS LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 3 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
267,672
346,766
Current assets
Stocks
5
336,655
392,694
Debtors
6
365,477
255,422
Cash at bank and in hand
448,783
442,676
1,150,915
1,090,792
Creditors: amounts falling due within one year
7
(154,217)
(232,890)
Net current assets
996,698
857,902
Total assets less current liabilities
1,264,370
1,204,668
Provisions for liabilities
(50,975)
(81,171)
Net assets
1,213,395
1,123,497
Capital and reserves
Called up share capital
101
101
Profit and loss reserves
1,213,294
1,123,396
Total equity
1,213,395
1,123,497

The notes on pages 5 to 8 form part of these financial statements.

INTERNATIONAL PHEROMONE SYSTEMS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2025
31 December 2025
- 4 -

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 8 July 2026
Mr G Hartley
Director
Company registration number 1824905 (England and Wales)
INTERNATIONAL PHEROMONE SYSTEMS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
1
Accounting policies
Company information

International Pheromone Systems Limited is a private company limited by shares incorporated in England and Wales. The registered office is Evolution House, Longacres Road, Clayhill Industrial Park, Neston, Cheshire, United Kingdom, CH64 3RL.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
25% Straight Line
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
10% Straight Line
Plant and equipment
25% Straight Line
Fixtures and fittings
25% Straight Line
Motor vehicles
25% Straight Line
INTERNATIONAL PHEROMONE SYSTEMS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 6 -

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

INTERNATIONAL PHEROMONE SYSTEMS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 7 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.10
Retirement benefits
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
19
19
3
Intangible fixed assets
Other
£
Cost
At 1 January 2025 and 31 December 2025
34,000
Amortisation and impairment
At 1 January 2025 and 31 December 2025
34,000
Carrying amount
At 31 December 2025
-
0
At 31 December 2024
-
0
INTERNATIONAL PHEROMONE SYSTEMS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
4
Tangible fixed assets
Leasehold land and buildings
Plant and equipment
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 January 2025
243,521
944,863
114,694
6,495
1,309,573
Additions
-
0
10,133
10,122
-
0
20,255
At 31 December 2025
243,521
954,996
124,816
6,495
1,329,828
Depreciation and impairment
At 1 January 2025
86,401
774,410
95,501
6,495
962,807
Depreciation charged in the year
24,352
65,215
9,782
-
0
99,349
At 31 December 2025
110,753
839,625
105,283
6,495
1,062,156
Carrying amount
At 31 December 2025
132,768
115,371
19,533
-
0
267,672
At 31 December 2024
157,120
170,453
19,193
-
0
346,766
5
Stocks
2025
2024
£
£
Stocks
336,655
392,694
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
220,656
93,608
Amounts owed by group undertakings
135,937
135,937
Other debtors
8,884
25,877
365,477
255,422
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
-
0
34,568
Trade creditors
27,010
107,303
Taxation and social security
57,407
12,386
Other creditors
69,800
78,633
154,217
232,890
2025-12-31 2025-01-01 false false false 08 July 2026 CCH Software CCH Accounts Production 2026.100 The principal activity of the company continued to be that of the manufacture of products to monitor and manage pests in agricultural and domestic environments.Mr G Hartley 1824905 2025-01-01 2025-12-31 1824905 bus:Director1 2025-01-01 2025-12-31 1824905 2025-12-31 1824905 2024-12-31 1824905 core:LandBuildings 2025-12-31 1824905 core:PlantMachinery 2025-12-31 1824905 core:FurnitureFittings 2025-12-31 1824905 core:MotorVehicles 2025-12-31 1824905 core:LandBuildings 2024-12-31 1824905 core:PlantMachinery 2024-12-31 1824905 core:FurnitureFittings 2024-12-31 1824905 core:MotorVehicles 2024-12-31 1824905 core:CurrentInventories 2025-12-31 1824905 core:CurrentInventories 2024-12-31 1824905 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 1824905 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 1824905 core:WithinOneYear 2025-12-31 1824905 core:WithinOneYear 2024-12-31 1824905 core:CurrentFinancialInstruments 2025-12-31 1824905 core:CurrentFinancialInstruments 2024-12-31 1824905 core:ShareCapital 2025-12-31 1824905 core:ShareCapital 2024-12-31 1824905 core:RetainedEarningsAccumulatedLosses 2025-12-31 1824905 core:RetainedEarningsAccumulatedLosses 2024-12-31 1824905 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 1824905 core:PatentsTrademarksLicencesConcessionsSimilar 2025-01-01 2025-12-31 1824905 core:LandBuildings core:LongLeaseholdAssets 2025-01-01 2025-12-31 1824905 core:PlantMachinery 2025-01-01 2025-12-31 1824905 core:FurnitureFittings 2025-01-01 2025-12-31 1824905 core:MotorVehicles 2025-01-01 2025-12-31 1824905 2024-01-01 2024-12-31 1824905 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 1824905 core:IntangibleAssetsOtherThanGoodwill 2025-12-31 1824905 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 1824905 core:LandBuildings core:LeasedAssetsHeldAsLessee 2024-12-31 1824905 core:PlantMachinery 2024-12-31 1824905 core:FurnitureFittings 2024-12-31 1824905 core:MotorVehicles 2024-12-31 1824905 2024-12-31 1824905 core:LandBuildings core:LeasedAssetsHeldAsLessee 2025-12-31 1824905 core:LandBuildings core:LeasedAssetsHeldAsLessee 2025-01-01 2025-12-31 1824905 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 1824905 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 1824905 bus:FRS102 2025-01-01 2025-12-31 1824905 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 1824905 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP